Treatment of protracted acute type B hepatitis with recombinant alpha-A-interferon. A pilot study
- PMID: 2921506
- DOI: 10.1016/0168-8278(89)90164-5
Treatment of protracted acute type B hepatitis with recombinant alpha-A-interferon. A pilot study
Abstract
Six individuals with protracted acute type B hepatitis were treated with recombinant alpha-A-interferon for 12 weeks. Two females eliminated the HBV completely, while 4 males did not respond. Response was preceded by a flare-up of the liver disease. It appears that responses to interferon are not higher in protracted acute type B hepatitis than in progressed chronic active hepatitis B. This assumption has to be proven in larger studies on a statistical basis.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
